IP Library › Assignment 028291/0168
Patent Assignment
Reel/Frame 028291/0168

Assignment of Assignor's Interest

Recorded: 2012-05-30 Pages: 8
Assignor
GENZYME CORPORATION
Executed: 2012-05-29
Assignee
ISIS PHARMACEUTICALS, INC.
2855 GAZELLE COURT, CARLSBAD, CALIFORNIA, 92010
Covered Properties (6)
Modulation of Huntingtin Expression
Modulation of Dystrophia Myotonica-Protein Kinase (Dmpk) Expression
Modulation of Huntingtin Expression
Patent: 8,906,873 →
Application: 13/395,188 →
Publication: US 2012/0252879
Modulation of Huntingtin Expression
Application: 61/241,853 →
Modulation of Dystrophia Myotonica-Protein Kinase (Dmpk) Expression
Application: 61/365,762 →
Modulation of Dystrophia Myotonica-Protein Kinase (Dmpk) Expression
Application: 61/478,021 →
Related Assignments (4)
Other recorded transfers of the patents in this record — the chain of ownership.
Assignment of Assignor's Interest May 11, 2012
From: HUNG, GENE; BENNETT, C. FRANK; FREIER, SUSAN M.; KORDASIEWICZ, HOLLY
To: ISIS PHARMACEUTICALS, INC.
Reel/Frame 028197/0703 →
Assignment of Assignor's Interest May 25, 2012
From: CHENG, SENG H.; SHIHABUDDIN, LAMYA; STANEK, LISA
To: GENZYME CORPORATION
Reel/Frame 028269/0242 →
Confirmatory License Jan 17, 2017
From: UNIVERSITY OF ROCHESTER
To: NATIONAL INSTITUTES OF HEALTH - DIRECTOR DEITR
Reel/Frame 041379/0563 →
Change of Name Jun 15, 2017
From: ISIS PHARMACEUTICALS, INC.
To: IONIS PHARMACEUTICALS, INC.
Reel/Frame 042822/0152 →